Stock listing
NASDAQ:GENB Generate Biomedicines, Inc. Stock
Home listing (NASDAQ) of Generate Biomedicines, Inc.
Follow Generate Biomedicines, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:GENB
$12.09 USD -0.97 (-7.4%)
Close on Oct 16, 2026
- Day range
- $11.84 – $13.22 USDOct 16, 2026
- Volume
- 1.07M sharesOct 16, 2026
- Market value
- $1.55B USDAt the close on Oct 16, 2026 · price × 128.4M shares outstanding
- Ticker
- NASDAQ:GENB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 13, 2026
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Latest deck · June 2026
Investor Presentation (June 2026)
Investor deck · 51 slides
Latest news
Decks
Investor Presentation (June 2026)
Investor deck · 51 slides · June 2026
ERS Congress 2025 (Late Breaker)
Conference · 11 slides · 2025
Generate Biomedicines, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 7 in the last 12 months · 7 in all · newest Oct 13, 2026 · oldest 2026
- Decks
- 2 decks · latest June 2026
Where Generate Biomedicines, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GENB · Home listing · This page | NASDAQ | United States | USD |
| BOATS:GENB | BOATS | United States | USD |
| BX Swiss:GENB | BX Swiss | Switzerland | CHF |
| BMV:GENB | BMV | Mexico | MXN |
Log in to ask 6ix AI your own questions about Generate Biomedicines, Inc.